The table below shows aTYR PHARMA INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
$190.00K
$0.00
$0.00
$0.00
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$7.32M
$22.13M
$15.38M
$11.81M
$14.81M
$13.97M
SG&A
LIFE annual revenue (10-K history)
aTYR PHARMA INC reported annual revenue of $190.00K for fiscal year 2025. That is down 19.1% from $235.00K in fiscal 2024. Over the 7 fiscal years shown, annual revenue declined from $422.00K (FY 2019) to $190.00K. Figures come from the company's audited annual reports as filed with the SEC.
